Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

994 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationships between plasma fatty acids in adults with mild, moderate, or severe COVID-19 and the development of post-acute sequelae.
Stromberg S, Baxter BA, Dooley G, LaVergne SM, Gallichotte E, Dutt T, Tipton M, Berry K, Haberman J, Natter N, Webb TL, McFann K, Henao-Tamayo M, Ebel G, Rao S, Dunn J, Ryan EP. Stromberg S, et al. Among authors: berry k. Front Nutr. 2022 Sep 14;9:960409. doi: 10.3389/fnut.2022.960409. eCollection 2022. Front Nutr. 2022. PMID: 36185653 Free PMC article.
Quality of Life (QoL) Is Reduced in Those with Severe COVID-19 Disease, Post-Acute Sequelae of COVID-19, and Hospitalization in United States Adults from Northern Colorado.
McFann K, Baxter BA, LaVergne SM, Stromberg S, Berry K, Tipton M, Haberman J, Ladd J, Webb TL, Dunn JA, Ryan EP. McFann K, et al. Among authors: berry k. Int J Environ Res Public Health. 2021 Oct 21;18(21):11048. doi: 10.3390/ijerph182111048. Int J Environ Res Public Health. 2021. PMID: 34769566 Free PMC article.
Persistent CD8+ T cell proliferation and activation in COVID-19 adult survivors with post-acute sequelae: a longitudinal, observational cohort study of persistent symptoms and T cell markers.
LaVergne SM, Dutt TS, McFann K, Baxter BA, Webb TL, Berry K, Tipton M, Stromberg S, Sullivan BM, Dunn J, Henao-Tamayo M, Ryan EP. LaVergne SM, et al. Among authors: berry k. Front Immunol. 2024 Jan 23;14:1303971. doi: 10.3389/fimmu.2023.1303971. eCollection 2023. Front Immunol. 2024. PMID: 38327763 Free PMC article.
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer.
Foote JB, Mattox TE, Keeton AB, Chen X, Smith FT, Berry K, Holmes TW, Wang J, Huang CH, Ward A, Mitra AK, Ramirez-Alcantara V, Hardy C, Fleten KG, Flatmark K, Yoon KJ, Sarvesh S, Nagaraju GP, Bandi DSR, Maxuitenko YY, Valiyaveettil J, Carstens JL, Buchsbaum DJ, Yang J, Zhou G, Nurmemmedov E, Babic I, Gaponeko V, Abdelkarim H, Boyd MR, Gorman G, Manne U, Bae S, El-Rayes BF, Piazza GA. Foote JB, et al. Among authors: berry k. Cancer Res. 2024 Dec 19. doi: 10.1158/0008-5472.CAN-24-0323. Online ahead of print. Cancer Res. 2024. PMID: 39700396
Validation and expansion of Baveno VII criteria for cACLD and CSPH based on liver stiffness and platelet count: Correlation with risk of hepatic decompensation and death.
Vutien P, Barnard Giustini A, Kim NJ, Moon AM, Hsu CN, Mezzacappa C, Borgerding JA, Johnson KM, VoPham T, Berry K, Beste LA, Kaplan DE, Taddei TH, Ioannou GN. Vutien P, et al. Among authors: berry k. Hepatology. 2024 Dec 17. doi: 10.1097/HEP.0000000000001183. Online ahead of print. Hepatology. 2024. PMID: 39689352
994 results